NCT05903612

Allergic Bronchopulmonary Aspergillosis Prescreening Study

A Prescreening Study to Diagnose Allergic Bronchopulmonary Aspergillosis in Selected Patients With Asthma

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: Community Pharmacology Services Ltd · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This prescreening study is being conducted to diagnose ABPA in selected patients with asthma and to increase the potential number of eligible participants for the ongoing Study 601-0018 of PUR1900 in subjects with ABPA. See: NCT05667662. Additionally, this prescreening study may provide information that could assist the conduct of future studies conducted by Pulmatrix.

Detailed description

See NCT05667662 for a detailed description fo the main ABPA study. This prescreening study is designed to diagnose ABPA in patients with asthma to potentially increase the number of eligible participants for the ongoing NCT05667662 study. This diagnosis will be confirmed through chest x-rays and a blood sample.

Conditions

• Allergic Bronchopulmonary Aspergillosis
• Asthma
• ABPA

Timeline

• Start date: 2024-01-10
• Primary completion: 2024-01-10
• Completion: 2024-01-10
• First posted: 2023-06-15
• Last updated: 2024-01-16

Locations

1 site across 1 country: United Kingdom